Goniothalamin induces apoptosis in vascular smooth muscle cells

K M Chan1, N F Rajab, M H A Ishak

  • 1Department of Biomedical Science, Faculty of Allied Health Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia.

Insights

Goniothalamin (GN) induces DNA damage and apoptosis in vascular smooth muscle cells (VSMCs), offering a potential therapeutic strategy for restenosis. Its cytotoxicity is more potent than rapamycin, suggesting promise in cardiovascular treatments.

Area of Science:

  • Cardiovascular Biology
  • Pharmacology
  • Cell Biology

Background:

  • Restenosis, a complication of coronary angioplasty, is driven by vascular smooth muscle cell (VSMC) proliferation.
  • Rapamycin and paclitaxel are established agents impacting VSMC proliferation in restenosis.
  • Understanding novel therapeutic mechanisms for restenosis is crucial.

Purpose of the Study:

  • To investigate the cytotoxic mechanisms of goniothalamin (GN) on VSMCs.
  • To compare the efficacy of GN with rapamycin in inhibiting VSMC proliferation and inducing cytotoxicity.
  • To elucidate the initial cellular events triggered by GN exposure.

Main Methods:

  • MTT cytotoxicity assay to determine IC(50) values.
  • Bromodeoxyuridine (BrdU) cell proliferation assay to assess proliferation inhibition.
  • Comet assay to detect DNA damage post-treatment.
  • Flow cytometry to quantify apoptotic cells.

Main Results:

  • Goniothalamin (GN) exhibited a lower IC(50) (4.4 microg/ml) than rapamycin (25 microg/ml) in VSMCs.
  • GN induced significant apoptosis in VSMCs (25.83% at 72h).
  • GN demonstrated comparable inhibition of VSMC proliferation to rapamycin.
  • A concentration-dependent increase in DNA damage was observed prior to GN-induced cytotoxicity.

Conclusions:

  • Goniothalamin (GN) induces DNA damage in VSMCs, leading to apoptosis and cytotoxicity.
  • GN shows potential as a therapeutic agent for restenosis, with higher potency than rapamycin.
  • The findings provide insights into the anti-restenosis mechanisms of GN.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.